Showing 4161-4170 of 6805 results for "".
- Short Course Radiation Best Longer Courses in Older Skin Cancer Patientshttps://practicaldermatology.com/news/short-case-radiation-best-longer-courses-in-older-skin-cancer-patients/2457899/Shorter courses of radiation seem to be better than longer ones for older patients receiving treatment for basal and squamous cell skin cancers, a recent Penn State College of Medicine physician’s st
- Allergan Rolls Out "Not Cool vs. Cool"CoolSculpting Campaign Starring Professional Male Athlete Brand Ambassadorshttps://practicaldermatology.com/news/allergan-rolls-out-not-cool-vs-coolcoolsculpting-campaign-starring-professional-male-athlete-brand-ambassadors/2457905/Allergan’s new "Not Cool vs. Cool" Multi-Channel Campaign for CoolSculpting® stars Professional Athlete Brand Ambassadors: Figure Skater Johnny Weir and Go
- Apple Update Brings Healthcare Records to Phoneshttps://practicaldermatology.com/news/apple-update-brings-healthcare-records-to-phones/2457906/Apple has introduced a significant update to the Health app with the iOS 11.3 beta introducing a feature that gives customers access to their medical records on their iPhone. The updated H
- Amazon, Berkshire Hathaway, JPMorgan Chase Partner on Healthcarehttps://practicaldermatology.com/news/amazon-berkshire-hathaway-jpmorgan-chase-partner-on-healthcare/2457907/Amazon, Berkshire Hathaway, and JPMorgan Chase & Co. are partnering in an effort to seek solutions for delivering healthcare to their employees. The three companies will pursue this objective through an independent company that is free from profit-making incentives and constraints, they said
- Dr. Brandt Skincare Rolls Out Two New Productshttps://practicaldermatology.com/news/dr-brandt-skincare-rolls-out-two-new-products/2457909/Dr. Brandt skincare is introducing Hydro Biotic Recovery Sleeping Mask and Antioxidant Water Booster. The new sleeping mask is powered by Dr. Brandt Skincare's Biotic Balancing Complex, an oligosaccharide and yogurt powder that helps restore n
- New Research Explains Why Women Who Have Been Pregnant Have Better Melanoma Outcomeshttps://practicaldermatology.com/news/new-research-explains-why-women-who-have-been-pregnant-have-better-melanoma-outcomes/2457922/For decades, research has associated female sex and a history of previous pregnancy with better outcomes after a melanoma diagnosis. Now, a research team from Perelman School of Medicine at the University of Pennsylvania says it may have determined the reason for the melanoma-protective effect.</
- Cochrane Review: Biologics Trump Other Systemics for Psohttps://practicaldermatology.com/news/cochrane-review-biologics-trump-other-systemic-meds-for-pso/2457924/Biologics appear to be the most effective systemic medicines for achieving a chronic plaque psoriasis score of PASI (Psoriasis Area and Severity Index) 90, according to a newly published Cochrane Revie
- New Ceramide-Infused Skin Barrier Product Reduces Costs for Ostomy Carehttps://practicaldermatology.com/news/new-ceramide-infused-skin-barrier-product-reduces-costs-for-ostomy-care/2457929/Ostomy patients using a new type of skin barrier product infused with ceramides may experience lower costs of care, according to a randomized trial published
- Smart Beauty Devices Take Center Stage at CES 2018https://practicaldermatology.com/news/smart-beauty-devices-take-center-stage-at-ces-2018/2457927/The Computer Electronics Show is known as the see-and-be scene for techies – and beauty products and devices always take center stage. “Shopping for skincare products can be an overwhelming and confusing experience for our consumer because she is uncertain about what her
- FDA Grants AbbVie's Upadacitinib Breakthrough Therapy Designation for Atopic Dermatitishttps://practicaldermatology.com/news/fda-grants-abbvies-upadacitinib-breakthrough-therapy-designation-for-atopic-dermatitis/2457932/The FDA granted Breakthrough Therapy Designation for AbbVie's investigational, once-daily oral JAK1-selective inhibitor upadacitinib (ABT-494) in adult patients with moderate to severe atopic dermatitis who are candidates for systemic therapy. This Breakthrough Therapy Designation is supporte